v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights
As of March 31, 2026 and December 31, 2025, we had the following outstanding warrants:

As of
March 31, 2026
As of
December 31, 2025
Number of Underlying SharesExercise PriceExpiration
June 2022 Warrants384,615384,615$9.10December 16, 2026
December 2021 Warrants182,630182,630$24.64June 7, 2027
567,245567,245
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense and the impact it had on operations for the periods presented (in thousands):
Three months ended
March 31,
20262025
Selling, general, and administrative— (4)
Total stock-based compensation$— $(4)
Schedule of Option Activity A summary of option activity under all outstanding stock incentive plans for the three months ended March 31, 2026 was presented as follows:
Number of
Options
Weighted
Average
Exercise
Price Per
Share
Weighted
Average
Remaining
Contractual
Life (in years)
Balance as of December 31, 20251,976 $9.91 
Granted— — 
Canceled/forfeited— — 
Expired— — 
Balance as of March 31, 20261,976 $9.91 3.0
Vested and expected to vest as of March 31, 20261,976 $9.91 3.0
Exercisable as of March 31, 20261,625 $11.55 3.0